Continuing Education
Completion Time:
Estimated time to complete this complimentary activity is 1 hour.
Target Audience:
Physicians and nurses who treat patients with wounds
Learning Objectives:
Upon completion of this educational activity, participants should be able to:
• Describe the range of clinical and biological abnormalities in the wound bed that can inhibit wound healing
• Define initial and maintenance debridement and describe the primary goals of each
• Discuss the scientific and clinical rationale for initial and maintenance debridement
• Name two tools that can be used to assess the adequacy of debridement and wound bed preparation in general
• Describe how to implement debridement within the context of an effective wound care strategy
• List several different methods of debridement.

MD/DO:
This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.
Nurses: ANCC: NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour (Provider Number 110-3-E-06). Provider approved by the California Board of Registered Nursing, Provider Number 13255, for 1 contact hour.

Off-Label/Unapproved Usage Disclosure:
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA.NACCME does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Planner and Faculty:
Dr. Falanga has disclosed that he is a consultant to Organogenesis.

Faculty:
Dr. Brem has disclosed that he is a consultant to Organogenesis. Dr. Ennis has disclosed that he is a consultant to Celleration and Accelecare Wound Centers. Dr. Ayello has disclosed that she is a consultant to 3M Health Care, Smith & Nephew, Hill- Rom, KCI, IVIVI, Sage, Mölnlycke, Coloplast, and Ross. She is a member of the speakers’ bureau for Smith & Nephew, KCI, Ross, and Hill- Rom. She has received other financial or material support from Gaymar, Healthpoint, NJHA (3M Health Care, Sage, and Healthpoint), LWW, Hollister, and WUWHS. Dr. Gould has disclosed that she has received grant/research support and is a scientific advisor to Diversified Clinical Services. She is a member of the speakers’ bureau for KCI. Dr.Wolcott has disclosed that he has received grant/research support from NIH. He is a member of the speakers’ bureau for Cubist and Pfizer.

Medical Writer: Amy Lindsay, PhD, has disclosed that she has no significant financial relationships.
Reviewer: Dr. Siegel has disclosed that he has no significant financial relationships.

Commercial Support: This activity is supported by an educational grant from Healthpoint.

Conflict of Interest Resolution/Content Validation: In compliance with ACCME Standards for Commercial Support and NACCME’s policy and procedure for resolving conflicts of interest, this continuing medical education activity was reviewed by Dr. Siegel in June 2008 for clinical content validity and to insure that the activity’s materials are fair, balanced, and free of bias toward the commercial supporters of the activity, that activity materials represent a standard of practice within the profession in the United States, and that any studies cited in the materials upon which recommendations are made are scientifically objective and conform to research principles generally accepted by the scientific community.

Sponsor:
This activity is sponsored by The North American Center for Continuing Medical Education.

Right click the link below to download your supplement.


Maintenance Debridement in the Treatment of Difficult-to-Heal Chronic Wounds